Ying He

机构：Central South University, Jiangsu T-mab BioPharma (China), Second Xiangya Hospital of Central South University, Qilu Hospital of Shandong University · ORCID：0009-0005-9427-0937

发表论文 55 篇 · 总被引 76 次 · h-index 5

代表论文

• Targeting immune cell migration as therapy for inflammatory disease: a review (2025 · Frontiers in Immunology · 被引 7)
• Peroxiredoxin 1 inhibits tumorigenesis by activating the NLRP3/GSDMD pathway to induce pyroptosis of colorectal cancer cells (2025 · World Journal of Gastroenterology · 被引 5)
• Recombinant Type XVII Collagen Inhibits EGFR/MAPK/AP-1 and Activates TGF-β/Smad Signaling to Enhance Collagen Secretion and Reduce Photoaging (2025 · Cosmetics · 被引 4)
• Abstract 6024: A novel chemical conjugated anti-CTLA-4 antibody with tumor microenvironment activation (2025 · Cancer Research)
• Supplementary Figure 15 from SIRT3 Negatively Regulates TFH-Cell Differentiation in Cancer (2024)
• Supplementary Figure 8 from SIRT3 Negatively Regulates TFH-Cell Differentiation in Cancer (2024)